Hadasa Gelander - Infimer External Director
| INFR Stock | ILA 60.40 0.10 0.17% |
Director
Dr. Hadasa Gelander serves as External Director at Infimer Ltd since February 24, 2011. She serves as chairwoman of the Audit, Compensation and Financial Statements Auditing committees. Her work experience includes the following roles Director at a variety of companies, Lecturer in Accounting at Hamichlala Leminhal, Ben Gurion University and Baruch College, New York. She holds a Bachelors degree in Management from Hamichlala Leminhal, a MBA degree, majoring in Finance and Accounting, from The Hebrew University of Jerusalem and a Doctorate in Philosophy degree in Management from Ben Gurion University. since 2011.
| Age | 50 |
| Tenure | 13 years |
| Professional Marks | MBA |
| Phone | 972 73 700 0266 |
| Web | http://www.infimer.com |
Infimer Management Efficiency
The company has return on total asset (ROA) of (0.3287) % which means that it has lost $0.3287 on every $100 spent on assets. This is way below average. Infimer's management efficiency ratios could be used to measure how well Infimer manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Dan Propper | Teva Pharmaceutical Industries | 73 | |
| Haim Levy | Bank Leumi Le Israel | 77 | |
| Yuli Tamir | Elbit Systems | 65 | |
| Ehood Nisan | Elbit Systems | 51 | |
| Ilan Biran | Bezeq Israeli Telecommunication | 70 | |
| Yitzhak Peterburg | Teva Pharmaceutical Industries | 65 | |
| Ester Dominissini | Bank Leumi Le Israel | 67 | |
| Yosef Yarom | Bank Hapoalim | 73 | |
| Ytzhak Edelman | Bezeq Israeli Telecommunication | 64 | |
| Ohad Marani | Bank Leumi Le Israel | 63 | |
| Shmuel BenZvi | Bank Leumi Le Israel | 57 | |
| Rosemary Crane | Teva Pharmaceutical Industries | 59 | |
| Dalya Lev | Bank Hapoalim | 71 | |
| Haggai Herman | Bezeq Israeli Telecommunication | 51 | |
| Yehoshua Gleitman | Elbit Systems | 69 | |
| Meir Wietchner | Bank Hapoalim | 52 | |
| Yedidia Stern | Bank Leumi Le Israel | 62 | |
| Ruben Krupik | Bank Hapoalim | 67 | |
| Mali Baron | Bank Hapoalim | 66 | |
| Amikam Shorer | Bezeq Israeli Telecommunication | 49 | |
| Dov Ninveh | Elbit Systems | 71 | |
Management Performance
| Return On Asset | -0.33 |
Infimer Leadership Team
Elected by the shareholders, the Infimer's board of directors comprises two types of representatives: Infimer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Infimer. The board's role is to monitor Infimer's management team and ensure that shareholders' interests are well served. Infimer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Infimer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Moshe Dayan, Chief Executive Officer | ||
| Asaf Tennenbaum, External Director | ||
| Shirley Behar, External Director | ||
| Hadas Gelander, External Director | ||
| Batya Many, Vice President - Finance | ||
| Tal Tamir, Director | ||
| Hadasa Gelander, External Director | ||
| Oren Zahavi, Vice President - Business Development | ||
| Eyal Ayalon, Director | ||
| Gosta Tixell, Independent Director | ||
| Avshalom Shilin, Director | ||
| Yuval Tamir, Chairman of the Board, CEO | ||
| Eli Zahavi, Director | ||
| Eliahu Zahavi, Director |
Infimer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Infimer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.33 | |||
| Operating Margin | (9.80) % | |||
| Current Valuation | 25.15 M | |||
| Shares Outstanding | 1.06 M | |||
| Shares Owned By Insiders | 14.32 % | |||
| Shares Owned By Institutions | 10.35 % | |||
| Price To Earning | (867.76) X | |||
| Price To Sales | 4,759 X | |||
| Revenue | 378 K | |||
| Gross Profit | (899 K) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infimer. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |